Oncogene expression in autoimmune and normal peripheral blood mononuclear cells

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Autoimmune diseases involve immune system dysregulation.
• Cellular oncogenes play roles in cell growth and differentiation.
• Aberrant oncogene expression is implicated in various diseases.

Purpose of the Study:

• To investigate protooncogene expression in peripheral blood mononuclear cells (PBMCs) from patients with autoimmune diseases.
• To determine if altered oncogene expression correlates with disease activity or specific autoimmune conditions.
• To explore the cellular basis for observed protooncogene expression patterns in systemic lupus erythematosus (SLE).

Main Methods:

• PBMCs were isolated from patients with autoimmune diseases and healthy controls.
• Northern blot analysis was used to quantify protooncogene RNA expression.
• B and T cells were purified from healthy volunteers for in vitro activation studies.

Main Results:

• Patients with SLE exhibited significantly higher c-myc protooncogene RNA levels compared to controls.
• Increased N-ras protooncogene expression was observed in patients with active autoimmune disease.
• SLE patients showed decreased c-myb and c-fos protooncogene levels, unlike those with other autoimmune illnesses.
• In vitro activation of normal B cells mimicked the protooncogene expression pattern seen in SLE patients.

Conclusions:

• Altered protooncogene expression in SLE may result from abnormal in vivo B cell activation.
• The distinct protooncogene expression patterns suggest different cellular involvements in various autoimmune diseases.